Current developments in gastric cancer: from molecular profiling to treatment strategy
Navarre Institute of Health Research · Vall d'Hebron Institute of Oncology · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
359
total citations
- FWCI
- 52.73
- Percentile
- 100%
- References
- 130
Citations per year
Authors
4- MAMaría AlsinaCorresponding
Navarre Institute of Health Research, Vall d'Hebron Institute of Oncology, Universidad de Navarra
- VAVirginia Arrazubi
Navarre Institute of Health Research, Universidad de Navarra
- MDMarc Díez
Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology
- JTJosep Tabernero
Vall d'Hebron Institut de Recerca, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology
Topics & keywords
Topics
Keywords
- Medicine
- Pembrolizumab
- Nivolumab
- Trastuzumab
- Chemotherapy
- Disease
- Cancer
- Immunotherapy
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.